The Chennai-based Orchid Chemicals and Pharmaceuticals has reported a 31.42 per cent fall in fall in net profit to Rs 5.76 crore for the quarter ending December 31, 2004. |
The company's turnover fell marginally to Rs 172.25 crore for the third quarter in 2004-05 compared with Rs 172.86 crore for the same period the previous year. |
Depreciation charges increased by 20.80 per cent to Rs 15.56 crore for the third quarter in 2004-05. Orchid had increased its stake to 75 per cent from the earlier level of 50 per cent in its US-based research joint venture, Bexel. |